DE60214676D1 - Hochaffine antagonisten der elr-cxc chemokine - Google Patents

Hochaffine antagonisten der elr-cxc chemokine

Info

Publication number
DE60214676D1
DE60214676D1 DE60214676T DE60214676T DE60214676D1 DE 60214676 D1 DE60214676 D1 DE 60214676D1 DE 60214676 T DE60214676 T DE 60214676T DE 60214676 T DE60214676 T DE 60214676T DE 60214676 D1 DE60214676 D1 DE 60214676D1
Authority
DE
Germany
Prior art keywords
antagonists
elr
cxc
chemokins
high affine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60214676T
Other languages
English (en)
Other versions
DE60214676T2 (de
Inventor
R Gordon
Fang Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Saskatchewan
Saskatchewan University of Technologies Inc
Original Assignee
University of Saskatchewan
Saskatchewan University of Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Saskatchewan, Saskatchewan University of Technologies Inc filed Critical University of Saskatchewan
Publication of DE60214676D1 publication Critical patent/DE60214676D1/de
Application granted granted Critical
Publication of DE60214676T2 publication Critical patent/DE60214676T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Power Steering Mechanism (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
DE60214676T 2001-03-01 2002-03-01 Hochaffine antagonisten der elr-cxc chemokine Expired - Lifetime DE60214676T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27318101P 2001-03-01 2001-03-01
US273181P 2001-03-01
PCT/CA2002/000271 WO2002070565A2 (en) 2001-03-01 2002-03-01 High-affinity antagonists of elr-cxc chemokines

Publications (2)

Publication Number Publication Date
DE60214676D1 true DE60214676D1 (de) 2006-10-26
DE60214676T2 DE60214676T2 (de) 2007-09-20

Family

ID=23042842

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60214676T Expired - Lifetime DE60214676T2 (de) 2001-03-01 2002-03-01 Hochaffine antagonisten der elr-cxc chemokine

Country Status (11)

Country Link
US (3) US7201895B2 (de)
EP (1) EP1363944B1 (de)
JP (1) JP2004534521A (de)
AT (1) ATE339447T1 (de)
AU (1) AU2002237136B2 (de)
CA (1) CA2439452C (de)
DE (1) DE60214676T2 (de)
DK (1) DK1363944T3 (de)
ES (1) ES2274957T3 (de)
HK (1) HK1062689A1 (de)
WO (1) WO2002070565A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274957T3 (es) * 2001-03-01 2007-06-01 University Of Saskatchewan Technologies Inc. Antagonistas de elevada afinidad de quimiocinas cxc de elr.
WO2007131352A1 (en) * 2006-05-16 2007-11-22 University Of Saskatchewan High-affinity antagonists of elr-cxc chemokines
EP2257303A4 (de) * 2008-02-12 2012-08-01 Univ Saskatchewan Verwendungen von modifiziertem elr-cxc-chemokin g31p
US8299019B2 (en) * 2008-02-12 2012-10-30 Gordon John R Uses of modified ELR-CXC chemokine G31P to treat cancer
KR101247641B1 (ko) 2010-10-22 2013-03-29 성균관대학교산학협력단 Ｃｘｃｒ２에 결합하는 펩타이드 리간드를 포함하는 감염성 및 염증성 질환 치료용 조성물
CN103619836A (zh) 2011-03-03 2014-03-05 德诺瓦姆德有限公司 抗菌剂/抗菌佐剂化合物及其方法
EP3011012B1 (de) 2013-06-18 2018-09-12 New York University Zelluläre faktoren in der zytotoxizität von staphylococcus-aureus-leukocidinen: neuartige therapeutische targets
US10075024B2 (en) 2015-05-22 2018-09-11 La-Z-Boy Incorporated Apparatus and method for wireless power transfer in furniture
WO2018106931A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
US10980739B2 (en) 2016-12-14 2021-04-20 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CN109022599A (zh) * 2018-10-08 2018-12-18 河南科技学院 检测奶牛CCL28基因单核苷酸多态性的试剂盒及RFLP方法及相关SNPs
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
EP3870261B1 (de) 2019-12-13 2024-01-31 Biora Therapeutics, Inc. Einnehmbare vorrichtung zur abgabe eines therapeutischen mittels an den magen-darm-trakt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665346A (en) * 1991-12-04 1997-09-09 Research Corporation Technologies, Inc. Human interleukin-8 analogs
AU6283996A (en) * 1995-06-20 1997-01-22 Chiron Corporation Polypeptides with interleukin-8 receptor binding
ES2274957T3 (es) 2001-03-01 2007-06-01 University Of Saskatchewan Technologies Inc. Antagonistas de elevada afinidad de quimiocinas cxc de elr.

Also Published As

Publication number Publication date
US7741434B2 (en) 2010-06-22
JP2004534521A (ja) 2004-11-18
US7201895B2 (en) 2007-04-10
DK1363944T3 (da) 2007-01-08
ATE339447T1 (de) 2006-10-15
HK1062689A1 (en) 2004-11-19
AU2002237136B2 (en) 2007-11-01
US20030077705A1 (en) 2003-04-24
WO2002070565A2 (en) 2002-09-12
DE60214676T2 (de) 2007-09-20
CA2439452A1 (en) 2002-09-12
US20070021593A1 (en) 2007-01-25
WO2002070565A9 (en) 2002-10-31
WO2002070565A3 (en) 2002-12-19
ES2274957T3 (es) 2007-06-01
EP1363944B1 (de) 2006-09-13
CA2439452C (en) 2012-05-15
US20090118469A1 (en) 2009-05-07
EP1363944A2 (de) 2003-11-26

Similar Documents

Publication Publication Date Title
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DE60214676D1 (de) Hochaffine antagonisten der elr-cxc chemokine
ATE541857T1 (de) Optimierte fc-varianten und herstellungsverfahren dafür
TNSN07196A1 (en) Potentiators of glutamate receptors
SG149693A1 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
SG167664A1 (en) 2,4-pyrimidinediamine compounds and their uses
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
DE60114617D1 (de) Zolpidem hemitartrat
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
ATE312096T1 (de) Neue verbindungen
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
DE60209359D1 (de) Lösungsmittelverklebungsverfahren
SE0001373D0 (sv) NPY Y1 receptor agonists and antagonists
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses
BRPI0507173A (pt) método para produzir polìmeros de polifenileno substituìdo
DE60218183D1 (de) Methoden für die konstruktion und screening von chemokine varianten
SE0202608D0 (sv) New sequences
SE0303418D0 (sv) New use 1
CY1117092T1 (el) Μοτιβα της οικογενειας παγκρεατικων πολυπεπτιδιων, πολυπεπτιδια και μεθοδοι που τα περιλαμβανουν
MXPA04001166A (es) Usos de citocina de mamifero; reactivos relacionados.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH, 805